← Back to headlines
ORIC Pharmaceuticals Reports GAAP EPS of -$0.30, Beating Estimates
ORIC Pharmaceuticals released its latest financial results, reporting a GAAP EPS of -$0.30, which beat estimates by $0.06.
23 Feb, 22:06 — 23 Feb, 22:06
ℹOnly 1 source covers this story
